Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Naturalistic driving data can identify elevated driving risk in adults with Type 1 diabetes.

Traffic injury prevention·2026

Same author

Assessing the relationships between migraine and driving risks, challenges and coping strategies.

Scientific reports·2026

Same author

A cortico-subthalamic circuit rapidly engages and releases inhibition of specific movements depending on the environmental context.

PLoS biology·2026

Same author

Classifying Cognitive Decline in Older Drivers from Behavior on Adverse Roads Detected Using Computer Vision.

Journal of transportation technologies·2026

Same author

Counting Zs: Determining the Monitoring Days Needed to Obtain Reliable Sleep Metrics in Older Adults with Mild Cognitive Impairment.

Behavioral sleep medicine·2026

Same author

Deciphering the mechanisms of impaired decision-making.

Social neuroscience·2026

Search research articles

Related Experiment Video

Updated: May 5, 2026

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects

Published on: September 18, 2012

COLLISION AVOIDANCE TRAINING USING A DRIVING SIMULATOR IN DRIVERS WITH PARKINSON'S DISEASE: A PILOT STUDY.

Jeffrey D Dawson¹, Matthew Rizzo, Steven W Anderson

¹Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA.

Proceedings of the ... International Driving Symposium on Human Factors in Driver Assessment, Training, and Vehicle Design

|November 26, 2013

Summary

This pilot study found that simulator training may improve driving safety for individuals with Parkinson's disease (PD). Participants showed fewer crashes and faster reaction times after training, suggesting potential benefits for PD driving performance.

More Related Videos

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research

Published on: December 18, 2020

Using a Virtual Reality Walking Simulator to Investigate Pedestrian Behavior

Using a Virtual Reality Walking Simulator to Investigate Pedestrian Behavior

Published on: June 9, 2020

Related Experiment Videos

Last Updated: May 5, 2026

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects

Published on: September 18, 2012

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research

Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research

Published on: December 18, 2020

Using a Virtual Reality Walking Simulator to Investigate Pedestrian Behavior

Using a Virtual Reality Walking Simulator to Investigate Pedestrian Behavior

Published on: June 9, 2020

Area of Science:

Neurology
Transportation Safety
Rehabilitation Medicine

Background:

Parkinson's disease (PD) significantly impacts driving abilities, leading to increased crash risks.
Previous simulator studies indicate impaired driving performance in PD patients compared to controls.

Purpose of the Study:

To evaluate the feasibility and potential effectiveness of a simulator-based training program for drivers with Parkinson's disease.
To assess changes in driving performance metrics, specifically crash frequency and reaction times, following simulator training.

Main Methods:

A pilot study involving eight drivers with Parkinson's disease.
Participants completed three simulator driving sessions over 1-2 week intervals.
The simulator featured varied visibility, traffic, and crash-risk scenarios involving encroaching vehicles.

Main Results:

A statistically significant reduction in reaction times to vehicle incursions was observed (p=0.006).
A trend towards reduced crashes was noted (p=0.059).
The simulator training program was found to be feasible for this population.

Conclusions:

Simulator training appears to be a potentially useful intervention for improving driving safety in individuals with Parkinson's disease.
Further research is warranted to explore training transfer, durability of effects, and real-world outcomes compared to standard interventions.